Backlash builds against prasugrel panel decision
Dr. Steven Nissen is the latest high-profile physician to join the pile-on over an FDA advisory panel's decision to exclude an outspoken critic of the antiplatelet drug prasugrel.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.